Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

Feb. 25, 1998

HIV Drug Developer Frustrated; Pursuing Studies In China

Feb. 25, 1998

Peptech Making Changes; Returning To Australia

Feb. 25, 1998

Lilly To Pay Xenova $35M For Heart Attack Drug

Feb. 25, 1998

Gene Found That Keeps Female Embryos Female

Feb. 25, 1998

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Feb. 25, 1998

Canadian Biotech Groups Merge To Form National Body

Feb. 25, 1998

Scientists Report Progress In Gene Disease Research

Feb. 18, 1998

Biota Licenses Potential Drug For Alzheimer's Disease

Feb. 18, 1998

CSL Boosts Half-Year Profit To A$14M, An 11 Percent Jump

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...